Development and psychometric testing of a breast cancer patient-profiling questionnaire

Breast Cancer: Targets and Therapy

Volumn 7, Issue , 2015, Pages 133-146

  Gorini, Alessandra ^a,b   Mazzocco, Ketti ^a,b   Gandini, Sara ^b   Munzone, Elisabetta ^b   McVie, Gordon ^b   Pravettoni, Gabriella ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Patient preferences; Patient physician communication; Personalized medicine; Questionnaire validation

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; BODY IMAGE; BREAST CANCER; CANCER PATIENT; COGNITION ASSESSMENT; CONSTRUCT VALIDITY; CONTENT VALIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; FACE VALIDITY; FACTORIAL ANALYSIS; FEMALE; FUNCTIONAL STATUS ASSESSMENT; GLOBAL SELF RATED HEALTH; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MEMORY ASSESSMENT; MIDDLE AGED; PERSONALIZED MEDICINE; PSYCHOMETRY; QUESTIONNAIRE; SELF CONCEPT; TEST RETEST RELIABILITY; VALIDATION PROCESS; YOUNG ADULT;

EID: 84930947088     PISSN: None     EISSN: 11791314     Source Type: Journal    
DOI: 10.2147/BCTT.S80014     Document Type: Article

References (44)

1. Aspinall MG, Hamermesh RG. Realizing the promise of personalized medicine. Harv Bus Rev. 2007;85(10):108–117, 165.
2. Peppercorn JM, Smith TJ, Helft PR, et al; American Society of Clinical Oncology. American society of clinical oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol. 2011;29(6):755–760.
3. Epstein RM, Franks P, Fiscella K, et al. Measuring patient-centered communication in patient-physician consultations: theoretical and practical issues. Soc Sci Med. 2005;61(7):1516–1528.
4. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA. 2002;288(23): 3027–3034.
5. Trudel JG, Leduc N, Dumont S. Perceived communication between physicians and breast cancer patients as a predicting factor of patients’ health-related quality of life: a longitudinal analysis. Psychooncology. 2014;23(5):531–538.
6. Citrin DL, Bloom DL, Grutsch JF, Mortensen SJ, Lis CG. Beliefs and perceptions of women with newly diagnosed breast cancer who refused conventional treatment in favor of alternative therapies. Oncologist. 2012;17(5):607–612.
7. Rattray J, Jones MC. Essential elements of questionnaire design and development. J Clin Nurs. 2007;16(2):234–243.
8. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.
9. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376.
10. Sprangers MA, Groenvold M, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14(10):2756–2768.
11. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.
12. Royle J, Lincoln NB. The Everyday Memory Questionnaire-revised: development of a 13-item scale. Disabil Rehabil. 2008;30(2): 114–121.
13. Schwarzer R, Jerusalem M, Weinman J, Wright S, Johnston M. Generalized self-efficacy scale. In: Measures in Health Psychology: A User’s Portfolio. Windsor: Nfer-Nelson; 1995:35–37.
14. Kruglanski AW, Atash MN, DeGrada E, Mannetti L, Pierro A, Webster DM. Psychological theory testing versus psychometric nay-saying: comment on Neuberg et al’s (1997) critique of the need for closure scale. J Pers Soc Psychol. 1997;73(5):1005–1016; discussion 1017–1029.
15. Polit DF, Beck CT. The content validity index: are you sure you know what’s being reported? Critique and recommendations. Res Nurs Health. 2006;29(5):489–497.
16. Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health. 2007;30(4):459–467.
17. Kane M. Current concerns in validity theory. Journal of Educational Measurement. 2001;38:319–342.
18. DeVon HA, Block ME, Moyle-Wright P, et al. A psychometric toolbox for testing validity and reliability. J Nurs Scholarsh. 2007;39(2): 155–164.
19. Fabrigar LR, Wegener DT, MacCallum RC, Strahan EJ. Evaluating the use of exploratory factor analysis in psychological research. Psychol Methods. 1999;4:272–299.
20. Horn JL. A rationale and test for the number of factors in factor analysis. Psychometrika. 1965;30:179–185.
21. Zwick WR, Velicer WF. Comparison of five rules for determining the number of components to retain. Psychol Bull. 1986;99:432–442.
22. Guilford JP. Factor analysis in a test-development program. Psychol Rev. 1948;55:79–94.
23. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Modeling. 1999;6(1):1–55.
24. Bartlett MS. Properties of sufficiency and statistical tests. Proceedings of the Royal Statistical Society. 1937;Series A 160:268–282.
25. Snedecor GW, Cochran WG. Statistical Methods. 8th ed. Ames: Iowa State University Press; 1989.
26. DeSalvo KB, Fisher WP, Tran K, Bloser N, Merrill W, Peabody J. Assessing measurement properties of two single-item general health measures. Qual Life Res. 2006;15(2):191–201.
27. Shadbolt B, Barresi J, Craft P. Self-rated health as a predictor of survival among patients with advanced cancer. J Clin Oncol. 2002; 20(10):2514–2519.
28. Taylor N, Absolom K, Snowden J, Eiser C; Late Effects Group Sheffield. Need for psychological follow-up among young adult survivors of childhood cancer. Eur J Cancer Care (Engl). 2012;21(1):52–58.
29. Arden-Close E, Absolom K, Greenfield DM, Hancock BW, Coleman RE, Eiser C; Late Effects Group Sheffield. Gender differences in self-reported late effects, quality of life and satisfaction with clinic in survivors of lymphoma. Psychooncology. 2011;20(11):1202–1210.
30. Spielberger CD, Gorssuch RL, Lushene PR, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press, Inc.; 1983.
31. Patrick DL, Ferketich SL, Frame PS, et al; National Institutes of Health State-of-the-Science Panel. National Institutes of Health State-Of-The-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15–17, 2002. J Natl Cancer Inst Monogr. 2004;(32):9–16.
32. Singer S, Das-Munshi J, Brähler E. Prevalence of mental health conditions in cancer patients in acute care – a meta-analysis. Ann Oncol. 2010;21(5):925–930.
33. Cheng KK, Yeung RM. Impact of mood disturbance, sleep disturbance, fatigue and pain among patients receiving cancer therapy. Eur J Cancer Care (Engl). 2013;22(1):70–78.
34. Schwarzer R, Scholz U. Cross-cultural assessment of coping resources: the general perceived self-efficacy scale. Presented at: Asian Congress of Health Psychology; August 28–29, 2000; Tokyo.
35. Bandura A. Self-Efficacy: The Exercise of Control. New York: Freeman; 1997.
36. Schwarzer R, editor. Self-Efficacy: Thought Control of Action. Washington, DC: Hemisphere; 1992.
37. Shiloh S, Koren S, Zakay D. Individual differences in compensatory decision-making style and need for closure as correlates of subjective decision complexity and difficulty. Pers Individ Dif. 2001;30(4): 699–710.
38. Webster DM, Kruglanski AW. Individual differences in need for cognitive closure. J Pers Soc Psychol. 1994;67(6):1049–1062.
39. Berman MG, Askren MK, Jung M, et al. Pretreatment worry and neurocognitive responses in women with breast cancer. Health Psychol. 2014;33(3):222–231.
40. Klepin HD, Geiger AM, Bandos H, et al. Cognitive factors associated with adherence to oral antiestrogen therapy: results from the cognition in the study of tamoxifen and raloxifene (Co-STAR) study. Cancer Prev Res (Phila). 2014;7(1):161–168.
41. Morone G, Iosa M, Fusco A, et al. Effects of a multidisciplinary educational rehabilitative intervention in breast cancer survivors: the role of body image on quality of life outcomes. Scientific World Journal. 2014;2014:451935.
42. Alacacioglu A, Ulger E, Varol U, et al. Depression, anxiety and sexual satisfaction in breast cancer patients and their partners-Izmir oncology group study. Asian Pac J Cancer Prev. 2014;15(24):10631–10636.
43. Gorini A, Pravettoni G. P5 medicine: a plus for a personalized approach to oncology. Nat Rev Clin Oncol. 2011;8(7):444.
44. Council NR. Cancer Care for the Whole Patient: Meeting Psychosocial Health Needs. Washington: The National Academies Press; 2008.